2009 Conference Publication Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical ProstatectomySamaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2009). Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy. 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston, MA, United States, Mar 07-13, 2009. NEW YORK: NATURE PUBLISHING GROUP. |
2008 Journal Article Ductal adenocarcinoma of the prostate - Current opinion and controversiesSamaratunga, Hemamali and Delahunt, Brett (2008). Ductal adenocarcinoma of the prostate - Current opinion and controversies. Analytical and Quantitative Cytology and Histology, 30 (4), 237-246. |
2008 Journal Article Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutationWillems, Amber J., Dawson, Sarah -J., Samaratunga, Hema, De Luca, Alessandro, Antill, Yoland C., Hopper, John L. and Thorne, Heather J. (2008). Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clinical Cancer Research, 14 (10), 2953-2961. doi: 10.1158/1078-0432.CCR-07-5237 |
2008 Journal Article Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progressionRamsay, Andrew J., Dong, Ying, Hunt, Melanie L., Linn, MayLa, Samaratunga, Hemamali, Clements, Judith A. and Hooper, John D. (2008). Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression. The Journal of Biological Chemistry, 283 (18), 12293-12304. doi: 10.1074/jbc.M709493200 |
2008 Conference Publication Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?Cheng, Liang, Gobbo, Stefano, Eccher, Albino, Eble, John, Delahunt, Brett, Grignon, David, Samaratunga, Hemamali, Martignoni, Guido, Zhang, Shaobo, Wang, Mingsheng, Cossu-Rocca, Paolo and Brunelli, Matteo (2008). Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?. NEW YORK: SPRINGER. |
2008 Journal Article A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locusMyers, Stephen A., Kaushal, Aneel, Dong, Ying, Lai, John, Tan, Olivia L., Bui, Loan T., Hunt, Melanie L., Digby, Matthew R., Samaratunga, Hemamali, Gardiner, Robert A., Clements, Judith A. and Hooper, John D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-399. doi: 10.1002/pros.20685 |
2008 Journal Article Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic functionDong, Ying, Matigian, Nick, Harvey, Tracey J., Samaratunga, Hemamali, Hooper, John D. and Clements, Judith A. (2008). Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function. Biological Chemistry, 389 (2), 99-109. doi: 10.1515/BC.2008.013 |
2008 Journal Article Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancerKelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486 |
2008 Conference Publication Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A. and Hooper, John D. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). 2nd International Symposium on Kallikrein and Kallikrein-Related Peptidases (ISK 2007), Santorini, Greece, 16-18 October 2007. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2008.078 |
2008 Journal Article Cellular angiofibroma of the scrotumSamaratunga, Hemamali and Fitzpatrick, Peter (2008). Cellular angiofibroma of the scrotum. Pathology, 40 (3), 330-333. doi: 10.1080/00313020701716409 |
2008 Conference Publication Any proportion of ductal adenocarcinoma of the prostate predicts higher stage diseaseSamaratunga, H., Delahunt, B., Duffy, D., Brown, I. and Yaxley, J. (2008). Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver, CO, United States, 1-7 March 2008. Amsterdam, Netherlands: Elsevier. |
2008 Conference Publication Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened populationSamaratunga, H., Delahun, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver CO, United States, Mar 01-07, 2008. London, United Kingdom: Nature Publishing Group. |
2008 Journal Article What is the molecular pathology of low-risk prostate cancer?Samaratunga, Hemamali and Epstein, Jonathan I. (2008). What is the molecular pathology of low-risk prostate cancer?. World Journal of Urology, 26 (5), 431-436. doi: 10.1007/s00345-008-0260-5 |
2008 Conference Publication Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened populationSamaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver Co, Mar 01-07, 2008. NEW YORK: NATURE PUBLISHING GROUP. |
2007 Journal Article Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polypSamaratunga, Hemamali and Letizia, Bernadette (2007). Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp. Pathology, 39 (5), 476-481. doi: 10.1080/00313020701570004 |
2007 Journal Article Significance of minute focus of adenocarcinoma on prostate needle biopsySamaratunga, Hemamali, Yaxley, John, Kerr, Kris, McClymont, Kelly and Duffy, David (2007). Significance of minute focus of adenocarcinoma on prostate needle biopsy. Urology, 70 (2), 299-302. doi: 10.1016/j.urology.2007.03.068 |
2007 Journal Article A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farre, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2007). A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 31 (4), 652-652. |
2007 Conference Publication Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluidGardiner, R. A., Burger, M. J., Landers, K. A., Roper, K., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Stening, S. and Lavin, M. F. (2007). Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid. Urological Society of Australia and New Zealand 60th Annual Scientific Meeting, Adelaide, Australia, 18-22 February 2007. London, UK: Blackwell Science. doi: 10.1111/j.1464-410X.2007.06719.x |
2006 Journal Article A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farree, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2006). A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 30 (11), 1489-1489. |
2006 Conference Publication The significance of finding a small focus of prostatic adenocarcinoma on needle biopsySamaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group. |